152 related articles for article (PubMed ID: 34249769)
1. Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma
Frontiers Editorial Office
Front Oncol; 2021; 11():721663. PubMed ID: 34249769
[TBL] [Abstract][Full Text] [Related]
2. Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.
Frontiers Editorial Office
Front Oncol; 2021; 11():721658. PubMed ID: 34277459
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.
Liao X; Gao Y; Liu J; Tao L; Wang D; Xie D; Mo S
Front Oncol; 2021; 11():670798. PubMed ID: 33905466
[TBL] [Abstract][Full Text] [Related]
4. Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.
Liao X; Gao Y; Liu J; Tao L; Xie J; Gu Y; Liu T; Wang D; Xie D; Mo S
Front Oncol; 2020; 10():1756. PubMed ID: 33014864
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway.
Yue D; Zhang D; Shi X; Liu S; Li A; Wang D; Qin G; Ping Y; Qiao Y; Chen X; Wang F; Chen R; Zhao S; Wang L; Zhang Y
Front Oncol; 2022; 12():860158. PubMed ID: 35280817
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.
Zeng YZ; Zhang YQ; Chen JY; Zhang LY; Gao WL; Lin XQ; Huang SM; Zhang F; Wei XL
Front Oncol; 2021; 11():767805. PubMed ID: 34692552
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma.
Shi J; Zhang Y; Wang J; Li J; Li Z
Front Oncol; 2020; 10():583499. PubMed ID: 33330061
[TBL] [Abstract][Full Text] [Related]
9. Retraction: STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma
Frontiers Editorial Office
Front Oncol; 2021; 11():761874. PubMed ID: 34557422
[TBL] [Abstract][Full Text] [Related]
10.
Onco Targets Ther; 2023; 16():817-818. PubMed ID: 37849468
[TBL] [Abstract][Full Text] [Related]
11. Retraction: Panax notoginseng saponins regulate VEGF to suppress esophageal squamous cell carcinoma progression
Fisher L
RSC Adv; 2021 Feb; 11(11):6258. PubMed ID: 35427054
[TBL] [Abstract][Full Text] [Related]
12. CCR7 enhances the angiogenic capacity of esophageal squamous carcinoma cells in vitro via activation of the NF-κB/VEGF signaling pathway.
Cai QY; Liang GY; Zheng YF; Tan QY; Wang RW; Li K
Am J Transl Res; 2017; 9(7):3282-3292. PubMed ID: 28804546
[TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4-NF-κB Pathway.
Fan G; Jiang X; Wu X; Fordjour PA; Miao L; Zhang H; Zhu Y; Gao X
Inflammation; 2016 Feb; 39(1):375-384. PubMed ID: 26639663
[TBL] [Abstract][Full Text] [Related]
14. lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1 [Retraction].
Onco Targets Ther; 2020; 13():12737. PubMed ID: 33335407
[TBL] [Abstract][Full Text] [Related]
15. Retraction: Corrigendum: CDX2/mir-145-5p/SENP1 Pathways Affect LNCaP Cells Invasion and Migration.
Frontiers Editorial Office
Front Oncol; 2021; 11():744980. PubMed ID: 34490130
[TBL] [Abstract][Full Text] [Related]
16. Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1298859. PubMed ID: 38115901
[TBL] [Abstract][Full Text] [Related]
17. Retraction: lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p.
Frontiers Editorial Office
Front Oncol; 2021; 11():841478. PubMed ID: 35036363
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis.
Xiao L; Mowery YM; Czito BG; Wu Y; Gao G; Zhai C; Wang J; Wang J
Front Oncol; 2022; 12():827810. PubMed ID: 35186759
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Dihydrocapsaicin inhibits cell proliferation and metastasis in melanoma
Shi S; Li C; Zhang Y; Deng C; Liu W; Du J; Li Q; Ji Y; Guo L; Liu L; Hu H; Liu Y; Cui H
Front Oncol; 2022; 12():1052365. PubMed ID: 36303842
[TBL] [Abstract][Full Text] [Related]
20. Retraction: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway.
Frontiers Editorial Office
Front Oncol; 2020; 10():714. PubMed ID: 32373542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
